Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-in-human study of patients with advanced solid tumors (Q82478744)
Jump to navigation
Jump to search
scientific article published on 12 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-in-human study of patients with advanced solid tumors |
scientific article published on 12 January 2010 |
Statements
Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-in-human study of patients with advanced solid tumors (English)
Michael S Gordon
Christopher S Sweeney
David S Mendelson
S Gail Eckhardt
Abraham Anderson
Darrin M Beaupre
Daniel Branstetter
Teresa L Burgess
Angela Coxon
Hongjie Deng
Paula Kaplan-Lefko
Ian M Leitch
Kelly S Oliner
Lucy Yan
Min Zhu
12 January 2010